share_log

Immunovant Q1 EPS $(0.35) Down From $(0.31) YoY

Benzinga Real-time News ·  Aug 5, 2022 07:50

Immunovant (NASDAQ:IMVT) reported quarterly losses of $(0.35) per share. This is a 12.9 percent decrease over losses of $(0.31) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment